 |
Full Conference Video Recordings
Available on USB Flash Drive $279 $159
On sale now for only $159
Sale ends November 14, 2026
($279 after conference)
This package features video recordings of all sessions recorded exactly as they happened at the Massachusetts General Hospital Psychiatry Academy "Psychedelics and Psychedelic Medicine" Conference, held November 13-14, 2026.
Includes video files of every session. This package allows you to review presentations and is a lasting valuable resource.
|
INCLUDES ALL OF THE PRESENTATIONS FROM THE CONFERENCE:
| Friday, November 13, 2026 |
|
| Psychedelic Pharmacology for Clinicians |
Franklin King, MD |
| Keynote: Psychedelic-Assisted Therapy: Evidence, Experience, and Ongoing Questions |
Stephen Ross, MD |
| Keynote Panel Discussion |
Franklin King, MD; Stephen Ross, MD |
| Cognitive Networks and the Neuroscience of Depression Under Psychedelics |
Sharmin Ghaznavi, MD, PhD |
| Plant Medicines and the Psychedelome |
Stephen Haggarty, PhD |
| Advanced Meditation and the Third Wave of Meditation Research |
Matthew Sacchet, PhD |
| Neurobiology & Brain States Panel Discussion |
Jerrold Rosenbaum, MD; Sharmin Ghaznavi, MD, PhD; Stephen Haggarty, PhD; Matthew Sacchet, PhD |
| Ketamine and Esketamine in Academic Psychiatry |
Cristina Cusin, MD |
| Ketamine-Assisted Psychotherapy and Coaching-Informed Care |
Maren Nyer, MD, PhD |
| Psychoanalysis and Psychotherapy in Psychedelic Treatment |
Roxanne Sholevar, MD |
| Psychedelics in Cancer Care: Update on State of Current Research |
Yvan Beaussant, MD, MSc |
| Therapeutic Models Panel Discussion |
Franklin King, MD; Cristina Cusin, MD; Maren Nyer, MD, PhD; Roxanne Sholevar, MD |
| Saturday, November, 2026 |
|
| Implementation Challenges in Psychedelic Care |
Peter Hendricks, PhD |
| Psychedelics & Borderline Personality Disorder: Too Risky, or Potential Treatment |
Jenna Traynor, PhD |
| MDMA-Assisted Therapy and Simultaneous Patient-Therapist Neuroimaging in Pain |
Vitaly Napadow, PhD |
| Clinical Expansion, Psychosomatics, and Translational Imaging Panel Discussion |
Franklin King, MD; Peter Hendricks, PhD; Jenna Traynor, PhD; Vitaly Napadow, PhD |
| Psychedelic Churches and Sacred Use |
Jeffrey Breau, PhD |
| Population-Level Risks in Naturalistic Psychedelic Use |
Grant Jones, PhD |
| Culture & Naturalistic Risk Panel Discussion |
Franklin King, MD; Jeffrey Breau, PhD; Grant Jones, PhD |
| Studying Psychedelics in Academic Medicine: Methodological and Conceptual Challenges |
Franklin King, MD |
| Music in Psychedelic Therapy Sessions |
Lisa Summer, PhD |
| Clinical Risks and Adverse Outcomes in Psychedelic Therapies |
Kelley O’Donnell, MD, PhD |
| Experience, Meaning, and Clinical Risk Panel Discussion |
Franklin King, MD; Lisa Summer, PhD; Kelley O’Donnell, MD, PhD |
|
